Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Reports 2 Percent Decline in Fiscal Q1 Revenues

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Accelrys today reported a 2 percent dip in revenues for its first fiscal quarter, as a profit in the year-ago period swung to a loss.

For the three months ended June 30, Accelrys posted revenue of $19.8 million compared to $20.1 million for the same quarter of the previous year.

The company reported a net loss of $1.6 million, or $0.06 per diluted share, for its first fiscal quarter compared to net income of $700,000, or $0.03 per diluted share, for the prior-year period.

Accelrys said that its net loss for the current quarter includes "business consolidation costs" of $1.7 million, but did not elaborate.

The company reported a 4 percent decline in first-quarter product-development costs, to $3.7 million from $3.9 million in the year-ago period.

Sales and marketing costs, meantime, inched up 3 percent to $8.4 million from $8.1 million, while general and administrative costs fell 9 percent to $3.3 million from $3.7 million.

As of June 30, the company held cash, cash equivalents, marketable securities, and restricted cash of $92.9 million.

The company said that its integration with Symyx Technologies, which it acquired on July 1, is proceeding as scheduled.

Accelrys said that it is changing its fiscal year end from March 31 to Dec. 31, effective for the period ended Dec. 31, 2010.

For the remaining six months of the year, Accelrys said it expects to report non-GAAP revenue — which includes revenue due to purchase accounting treatment of deferred revenue related to the Symyx acquisition — of between $80 million and $82 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.